Dentsply Sirona Inc. (XRAY): Price and Financial Metrics

Dentsply Sirona Inc. (XRAY): $31.48

0.50 (+1.61%)

POWR Rating

Component Grades














  • XRAY scores best on the Value dimension, with a Value rank ahead of 81.43% of US stocks.
  • The strongest trend for XRAY is in Quality, which has been heading down over the past 179 days.
  • XRAY ranks lowest in Sentiment; there it ranks in the 3rd percentile.

XRAY Stock Summary

  • DENTSPLY SIRONA INC's market capitalization of $6,735,338,507 is ahead of 79.9% of US-listed equities.
  • DENTSPLY SIRONA INC's stock had its IPO on April 25, 1991, making it an older stock than 85.31% of US equities in our set.
  • Over the past twelve months, XRAY has reported earnings growth of -260.8%, putting it ahead of just 6.19% of US stocks in our set.
  • Stocks that are quantitatively similar to XRAY, based on their financial statements, market capitalization, and price volatility, are XRX, AOUT, TG, SATS, and TRVG.
  • Visit XRAY's SEC page to see the company's official filings. To visit the company's web site, go to

XRAY Valuation Summary

  • In comparison to the median Healthcare stock, XRAY's price/earnings ratio is 28.41% lower, now standing at 16.
  • Over the past 243 months, XRAY's EV/EBIT ratio has gone down 2.1.

Below are key valuation metrics over time for XRAY.

Stock Date P/S P/B P/E EV/EBIT
XRAY 2022-11-01 1.6 1.3 16.0 14.1
XRAY 2022-10-31 1.6 1.3 15.9 14.0
XRAY 2022-10-28 1.6 1.3 15.9 14.0
XRAY 2022-10-27 1.6 1.3 15.8 13.9
XRAY 2022-10-26 1.6 1.3 16.0 14.0
XRAY 2022-10-25 1.6 1.3 15.7 13.8

XRAY Growth Metrics

    Its 2 year revenue growth rate is now at 4.49%.
  • The 3 year revenue growth rate now stands at 3.99%.
  • The 4 year net cashflow from operations growth rate now stands at 5.22%.
XRAY's revenue has moved up $157,600,000 over the prior 33 months.

The table below shows XRAY's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 4,135 660 345
2021-12-31 4,251 657 421
2021-09-30 4,245.3 698.5 417.5
2021-06-30 4,071.1 733.6 368.3
2021-03-31 3,494.7 694.7 173.9
2020-12-31 3,342 635 -83

XRAY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • XRAY has a Quality Grade of C, ranking ahead of 67.88% of graded US stocks.
  • XRAY's asset turnover comes in at 0.443 -- ranking 108th of 186 Medical Equipment stocks.
  • ZBH, PEN, and IVC are the stocks whose asset turnover ratios are most correlated with XRAY.

The table below shows XRAY's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.443 0.538 0.150
2021-03-31 0.389 0.506 0.077
2020-12-31 0.383 0.496 -0.003
2020-09-30 0.395 0.503 -0.002
2020-06-30 0.409 0.514 0.008
2020-03-31 0.471 0.539 0.058

XRAY Price Target

For more insight on analysts targets of XRAY, see our XRAY price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $73.17 Average Broker Recommendation 1.54 (Moderate Buy)

XRAY Stock Price Chart Interactive Chart >

Price chart for XRAY

XRAY Price/Volume Stats

Current price $31.48 52-week high $58.70
Prev. close $30.98 52-week low $26.48
Day low $30.68 Volume 614,300
Day high $31.57 Avg. volume 2,250,012
50-day MA $29.73 Dividend yield 1.59%
200-day MA $38.34 Market Cap 6.77B

Dentsply Sirona Inc. (XRAY) Company Bio

Dentsply Sirona is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million. (Source:Wikipedia)

XRAY Latest News Stream

Event/Time News Detail
Loading, please wait...

XRAY Latest Social Stream

Loading social stream, please wait...

View Full XRAY Social Stream

Latest XRAY News From Around the Web

Below are the latest news stories about DENTSPLY SIRONA INC that investors may wish to consider to help them evaluate XRAY as an investment opportunity.

Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA (XRAY) and GlycoMimetics (GLYC)

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on DENTSPLY SIRONA (XRAY – Research Report) and GlycoMimetics (GLYC – Research Report) with bullish sentiments. DENTSPLY SIRONA (XRAY) In a report released today, Brandon Couillard from Jefferies maintained a Buy rating on DENTSPLY SIRONA, with a price target of $37.00. The company's shares closed last Friday at $31.13, close to its 52-week low of $26.48.

Catie Powers on TipRanks | November 21, 2022

Analysts Are Neutral on Top Healthcare Stocks: DENTSPLY SIRONA (XRAY), Evotec AG (EVO)

Analysts fell to the sidelines weighing in on DENTSPLY SIRONA (XRAY – Research Report) and Evotec AG (EVO – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks. DENTSPLY SIRONA (XRAY) In a report released today, Nathan Rich from Goldman Sachs maintained a Hold rating on DENTSPLY SIRONA, with a price target of $34.00. The company's shares closed last Wednesday at $31.11, close to its 52-week low of $26.48. According to TipRanks.

Brian Anderson on TipRanks | November 16, 2022

Barrington Sticks to Their Buy Rating for DENTSPLY SIRONA (XRAY)

Barrington analyst Michael Petusky maintained a Buy rating on DENTSPLY SIRONA (XRAY - Research Report) today and set a price target of $40.00. The company's shares closed yesterday at $30.35.According to TipRanks, Petusky is a 4-star analyst with an average return of 7.0% and a 49.71% success rate. Petusky covers the Healthcare sector, focusing on stocks such as Anika Therapeutics, Henry Schein, and Landec.In addition to Barrington, DENTSPLY SIRONA also received a Buy from Morgan Stanley's Erin Wright in a report issued yesterday. However, on the same day, Piper Sandler maintained a Hold rating on DENTSPLY SIRONA (NASDAQ: XRAY).

Austin Angelo on TipRanks | November 15, 2022

Dentsply gains on activist speculation amid 13F filing

Dentsply Sirona (XRAY) rose 3.7% on speculation of a potential activist investor following a Morgan Stanley 13F filing.Morgan Stanley was the second biggest buyer of Dentsply (XRAY) in…

Seeking Alpha | November 15, 2022

DENTSPLY SIRONA (XRAY) Q3 Earnings & Revenues Miss Estimates

Despite a year-over-year decline in both earnings and revenues, DENTSPLY SIRONA's (XRAY) third-quarter results benefit from the Technologies & Equipment business.

Yahoo | November 15, 2022

Read More 'XRAY' Stories Here

XRAY Price Returns

1-mo 3.18%
3-mo -5.94%
6-mo N/A
1-year -36.00%
3-year -43.28%
5-year -51.65%
YTD -42.99%
2021 7.32%
2020 -6.59%
2019 53.14%
2018 -43.00%
2017 14.66%

XRAY Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full XRAY Dividend History

Continue Researching XRAY

Want to see what other sources are saying about DENTSPLY SIRONA Inc's financials and stock price? Try the links below:

DENTSPLY SIRONA Inc (XRAY) Stock Price | Nasdaq
DENTSPLY SIRONA Inc (XRAY) Stock Quote, History and News - Yahoo Finance
DENTSPLY SIRONA Inc (XRAY) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8206 seconds.